OUTLOOK THERAPEUTICS Net Worth
OUTLOOK THERAPEUTICS Net Worth Breakdown | OTLK |
OUTLOOK THERAPEUTICS Net Worth Analysis
OUTLOOK THERAPEUTICS's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including OUTLOOK THERAPEUTICS's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of OUTLOOK THERAPEUTICS's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform OUTLOOK THERAPEUTICS's net worth analysis. One common approach is to calculate OUTLOOK THERAPEUTICS's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares OUTLOOK THERAPEUTICS's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing OUTLOOK THERAPEUTICS's net worth. This approach calculates the present value of OUTLOOK THERAPEUTICS's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of OUTLOOK THERAPEUTICS's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate OUTLOOK THERAPEUTICS's net worth. This involves comparing OUTLOOK THERAPEUTICS's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into OUTLOOK THERAPEUTICS's net worth relative to its peers.
Enterprise Value |
|
To determine if OUTLOOK THERAPEUTICS is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding OUTLOOK THERAPEUTICS's net worth research are outlined below:
| OUTLOOK THERAPEUTICS generated a negative expected return over the last 90 days | |
| OUTLOOK THERAPEUTICS has high historical volatility and very poor performance | |
| OUTLOOK THERAPEUTICS has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (58.98 M) with loss before overhead, payroll, taxes, and interest of (42.33 M). | |
| OUTLOOK THERAPEUTICS INC currently holds about 26.02 M in cash with (42.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| OUTLOOK THERAPEUTICS has a very weak financial position based on the latest SEC disclosures | |
| Roughly 36.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: Symbol Lookup |
OUTLOOK THERAPEUTICS uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in OUTLOOK THERAPEUTICS INC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to OUTLOOK THERAPEUTICS's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of December 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Know OUTLOOK THERAPEUTICS's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as OUTLOOK THERAPEUTICS is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OUTLOOK THERAPEUTICS INC backward and forwards among themselves. OUTLOOK THERAPEUTICS's institutional investor refers to the entity that pools money to purchase OUTLOOK THERAPEUTICS's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Woodline Partners Lp | 2024-09-30 | 151.5 K | Northern Trust Corp | 2024-09-30 | 118.9 K | Federated Hermes Inc | 2024-09-30 | 91.4 K | Charles Schwab Investment Management Inc | 2024-09-30 | 51.5 K | Lvw Advisors, Llc | 2024-09-30 | 47.7 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 43.7 K | Susquehanna Fundamental Investments, Llc | 2024-06-30 | 41 K | Xtx Topco Ltd | 2024-09-30 | 37.3 K | Goldman Sachs Group Inc | 2024-09-30 | 35.6 K | Great Point Partners Llc | 2024-06-30 | 1.7 M | Tang Capital Management Llc | 2024-09-30 | 1.6 M |
Follow OUTLOOK THERAPEUTICS's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 47.55 M.Market Cap |
|
Project OUTLOOK THERAPEUTICS's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.61) | (2.75) | |
| Return On Capital Employed | 5.22 | 5.48 | |
| Return On Assets | (2.61) | (2.75) | |
| Return On Equity | 1.03 | 1.08 |
When accessing OUTLOOK THERAPEUTICS's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures OUTLOOK THERAPEUTICS's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of OUTLOOK THERAPEUTICS's profitability and make more informed investment decisions.
Evaluate OUTLOOK THERAPEUTICS's management efficiency
OUTLOOK THERAPEUTICS INC has return on total asset (ROA) of (0.8369) % which means that it has lost $0.8369 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0365) %, meaning that it created substantial loss on money invested by shareholders. OUTLOOK THERAPEUTICS's management efficiency ratios could be used to measure how well OUTLOOK THERAPEUTICS manages its routine affairs as well as how well it operates its assets and liabilities. At this time, OUTLOOK THERAPEUTICS's Return On Capital Employed is quite stable compared to the past year. Return On Equity is expected to rise to 1.08 this year, although the value of Return On Tangible Assets will most likely fall to (2.75). At this time, OUTLOOK THERAPEUTICS's Total Current Liabilities is quite stable compared to the past year. Change To Liabilities is expected to rise to about 1.4 M this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 25.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | -3.9 K | -3.7 K | |
| Tangible Book Value Per Share | -3.9 K | -3.7 K | |
| Enterprise Value Over EBITDA | 0.20 | 0.21 | |
| Enterprise Value Multiple | 0.20 | 0.21 | |
| Enterprise Value | 60.7 M | 97.1 M |
The decision-making processes within OUTLOOK THERAPEUTICS are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Enterprise Value Revenue 26.101 | Revenue 5.9 M | Quarterly Revenue Growth 6.583 | Revenue Per Share 0.119 | Return On Equity (0.04) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OUTLOOK THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on OUTLOOK THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OUTLOOK THERAPEUTICS insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
OUTLOOK THERAPEUTICS Corporate Filings
8K | 27th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 3rd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 26th of June 2024 Other Reports | ViewVerify |
OUTLOOK THERAPEUTICS Earnings per Share Projection vs Actual
OUTLOOK THERAPEUTICS Corporate Management
| Terry Dagnon | Chief Officer | Profile | |
| Balu Balasubramanian | Advisor | Profile | |
| Jeffrey Evanson | Chief Officer | Profile | |
| Jedd Comiskey | Senior Europe | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.06) | Revenue Per Share 0.119 | Quarterly Revenue Growth 6.583 | Return On Assets (0.84) | Return On Equity (0.04) |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.